California Society of Health-System Pharmacists

Stronger together! 🤝🚀 Thank you to Octapharma for being a key sponsor of Pharmacy Policy & Legislative Day 2026. Your partnership allows CSHP to bring the most pressing issues facing CA pharmacists directly to the halls of government. 🏛️

Spotlight: Minh Thu Nguyen, CSHP Board Member 📢💊 From advanced biologics to AI, the pharmacy landscape is shifting. Dr. Nguyen shares why pharmacists' clinical expertise is the key to providing patient clarity and driving advocacy. Read her vision ➡️ bit.ly/47G1VT0

.@US_FDA Approves New Treatment for Linear Growth in Pediatric Patients The FDA has approved a new treatment to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. More: bit.ly/4lNcAkK

AB 2571 is moving—now it’s your turn! 🏛️🚀 Our sponsored bill has passed the Assembly Health Committee, but the work doesn't stop here. Join us on 4/7 for Pharmacy Policy & Legislative Day! 💰 $80 Pharmacists | $40 Techs/Students 🔗 Register: cshp.org/PPLD-2026

Student Town Hall: Spring 2026! 🎓💻 Join CSHP on April 22nd at 6:00 PM PT for an interactive session focused on YOUR future. Get expert advice on: 🔹 Residency & Career Paths 🔹 CSHP Student Resources 🔹 Leadership & Advocacy Register for FREE ➡️ cshp.org/TownHall4-22-26

.@CAPublicHealth Finalizes Population-Based Prevention Strategy The CDPH has finalized its population-based prevention strategy for California’s behavioral health transformation effort. More: bit.ly/4bAT0Dv

California Pharmacy Policy & Legislative Day Panel Announcement! Join us at #PPLD2026 for a powerhouse panel: ✅ Anne Sodergren ✅ Dr. Seung Oh ✅ Dr. Kyle Robb 📍 Sacramento, CA | April 7 💰 $80 Pharmacists | $40 Techs/Students Register➡️cshp.org/PPLD-2026

ADVANCE YOUR CAREER! 🎓🚀 Registration is now OPEN for our upcoming Advanced Pharmacist Practitioner (APP) sessions! Join Dr. Eric Ip for 38 hours of high-level CPE. 🗓️ April 1 (Next Session!) 🗓️ May 13 (NEW) 🗓️ June 24 (NEW) Register➡️ cshp.org/CP_AdvancedPha…

.@US_FDA Approves New Treatment for Hyperarginemia The FDA has approved a new treatment for adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1-D), in conjunction with dietary protein restriction. More: bit.ly/4rgF4UX

CALL FOR SPEAKERS: Seminar 2026! 🎤🏰 Help us shape the future of pharmacy in Anaheim, Nov 5-8! Looking for experts in: 🤖 AI ⚖️ Policy 💊 Clinical Pearls 📈 Workforce Dev ...and more! ⏳ Deadline: May 3rd 🔗 Submit: cshp.org/S26_CFS_Home

WIN: AB 2571 is moving to Consent! 🏛️📢 Great news—our sponsored bill is advancing to Assembly Appropriations! Huge thanks to Dr. Jeff Jolliff & Dr. Shabnam Gaskari for their readiness to advocate for CA pharmacy. Submit your support letters here: bit.ly/4dEH8D6

CALL for CSHP 2027 Board Nominations! 📣 We are seeking dedicated members to join our 2027 Board of Directors. ✅ Self-nominations encouraged ✅ Prior experience not required ✅ Expand your professional influence Deadline: April 10, 2026 Nominate ➡️ cshp.org/CSHP_Nominatio…

Board Member Spotlight: Martin Iyoya, CSHP President-Elect 🏥📢 40+ years of health-system leadership. A champion for SB 493 and pharmacist provider status. A visionary for the next generation of pharmacy professionals. Read his full spotlight at ➡️ bit.ly/4slkoga

SHAPE THE FUTURE! 🏛️💊 Registration for PPLD 2026 is now live! Join CSHP in Sacramento on April 7th to help advocate for the laws that impact your practice. Register here ➡️ cshp.org/PPLD-2026

.@US_FDA Launches New Platform for Analyzing Adverse Event Reports The U.S. Food and Drug Administration (FDA) launches a new adverse event look-up tool that modernizes and provides transparency into the safety of regulated products. More: bit.ly/4rIZiqY

Join CSHP’s Compounding Task Force on March 24th at 3:30 PM PT for a deep dive into the new CA hazardous drug compounding regulations. Get practical insights on: ✅ Facility Design & PPE ✅ Survey Readiness ✅ Real-world Implementation Register ➡️ cshp.org/CSHP_Webinar3-…

.@CAPublicHealth Recommends Immunizing Infants with RSV Monoclonal Antibodies The CDPH recommends that, due to ongoing respiratory syncytial virus (RSV) disease activity, infants continue to be immunized through April 30, 2026. More: bit.ly/4djfJqc

How & Why Advocate? 🏛️💊 Don't miss our upcoming FREE webinar on March 26th at 6:00 PM PT! Join speaker Brian Kawahara to learn the "Do's and Don'ts" of legislative communication and how to shape the future of pharmacy practice. Register➡️ bit.ly/4lF4cDZ

14 DAYS TO GO! ⏳🏰 The countdown to #Seminar2026 at the Disneyland® Resort is on! Get ready for: ✨ Expert-led CPE ✨ Premier networking ✨ One of the largest west-coast pharmacy conferences Are you ready for the magic? ✨ Register starting April 1st!

.@US_FDA Approves New Treatment for Schizophrenia and Bipolar I Disorder The FDA has approved a new treatment for adults with schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. More: bit.ly/4rgF4UX